M Performance Standards for Antimicrobial. Susceptibility Testing. This document includes updated tables for the Clinical and. Laboratory Standards. The tables in CLSI document M,1 when used in conjunction with this standard, represent the most current information for drug selection. [DOWNLOAD] Clsi Guidelines M S23 PDF [BOOK]. Book file PDF easily for everyone and every device. You can download and read online.
|Published (Last):||22 June 2013|
|PDF File Size:||10.66 Mb|
|ePub File Size:||19.1 Mb|
|Price:||Free* [*Free Regsitration Required]|
In contrast, when tested against streptococci, the impact of the revised method on the telavancin MIC results was less pronounced, which was similar to those observed for the other lipoglycopeptides 45. Abstract The reference broth microdilution BMD antimicrobial susceptibility testing method for telavancin was revised to include dimethyl sulfoxide DMSO as a solvent and diluent for frozen-form panel preparation, following the CLSI recommendations for water-insoluble agents.
Frozen-form panels produced according to the previously established susceptibility testing method were manufactured, following the previous CLSI recommendations MS23 However, Streptococcus pneumoniae had Mm100 50 results of 0.
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci. Environmental Standards and Trade Volume. Advances in MicrobiologyVol. There is a version specifically designed for pharmacists to enhance the implementation of M clso tailored to their organization. These results suggest that i P is necessary for a more accurate MIC determination clis telavancin and previous studies underestimated the drug’s in vitro potency due to drug loss because of binding m100 plastic surfaces 1213— 15 and ii similar to dalbavancin and oritavancin, presence of LHB provides an effect similar to that of P It is also important to mention that although this revised method provides lower MIC determinations for telavancin, the antimicrobial susceptibility profile remains similar to that established by using the previous BMD method 1213— Methicillin-resistant Staphylococcus aureus MRSA is a multi-drug resistant m100, which is responsible for increasing cases of serious diseases, including life-threatening diseases and nosocomial and community-acquired infections.
MS23 includes a dosage regimen for imipenem for Pseudomonas aeruginosa and new information for detection of inducible clindamycin resistance using the D-zone test or broth microdilution for Streptococcus pneumoniae.
Less-significant MIC decreases 1 to 2 log 2 dilution steps were observed when testing streptococci in broth supplemented with blood, which showed similar MIC 50 values for both methods. Differences m1000 MIC results between frozen-form BMD methods were less significant for the streptococci, where the majority of MIC values obtained by the previous method were only 1 doubling dilution step higher than those obtained by the revised method Table 1.
The previous method generated results against all E. TABLE 3 MIC result variations and summary of essential agreement rates between dry-form broth microdilution formulation panel Sensititre and revised reference method for telavancin. Footnotes Published ahead of print 14 July clsu In contrast, the disk diffusion methods with oxacillin and cefoxitin showed lower sensitivity Among candidate dry-form panels tested, all had EA rates above the minimal acceptable target i.
These changes were shown to improve drug solubility during panel preparation DMSO and drug availability in the well plastic plates Presulting in a more accurate in vitro assessment of telavancin MIC determinations data on file; Theravance, Inc. Rhombergand Ronald N.
The authors have paid a fee to allow immediate free access to this article.
South San Francisco, CA. The purpose of this study was to fully evaluate telavancin MIC results when using the revised BMD method compared with those obtained by the previous CLSI method when tested against a larger collection of clinically relevant strains.
Updated Version of CLSI’s Best-Selling Standard-MSis Now Available – IFCC
Comparative surveillance study of telavancin activity against recently collected Gram-positive clinical isolates from across the United States. Laboratory identification of MRSA is crucial and essential both for initiation of appropriate antimicrobial therapies and for effective infection control strategies that are designed to limit the spread of MRSA.
MendesPaul R. Guidance for industry and FDA. Initial studies using this revised method observed that the MIC 50 results for telavancin were 4- to 8-fold lower than those obtained by the previous applied method use of DMSO and water as solvent and diluent for panel preparation, respectively, and no P supplementation when tested against staphylococci and enterococci, but minimal differences were observed when testing streptococci data on file; JMI Laboratories.
In summary, these study results demonstrate that the previous BMD method adopted by CLSI use of DMSO as dlsi solvent and diluent for panel preparation and addition of P dlsi the broth ensures a proper assessment of the telavancin MIC determination, especially when tested against staphylococci and enterococci. TABLE 1 MIC result variations and summary of essential agreement rates between previously established broth microdilution method and revised reference method for telavancin.
A five-year international surveillance program.
Communications and Publications
The revised method provided MIC results 2- to 8-fold lower than the previous method when tested against staphylococci and enterococci, resulting in MIC 50 values of 0. MHB was supplemented with 2. Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA hospitals MIC result variations and summary of essential agreement rates n100 previously established broth microdilution method and revised reference method for telavancin.